NCT05932095

Brief Summary

In recent years, the number of people with symptoms of anxiety are on the rise. TCM Daoyin is a promising intervention for anxiety. This study is designed to allow researchers to better understand the changes in anxiety symptom, brain activity, and immune function during patients with anxiety states receiving TCM Daoyin intervention. Thus, the aims of the prospective randomized study are: (1) to examine the effects of TCM Daoyin training on reducing symptoms of anxiety, (2) to measure brain activity by using functional magnetic resonance imaging (fMRI), and (3) to assess Immune function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

June 13, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 6, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

June 11, 2023

Last Update Submit

March 31, 2025

Conditions

Keywords

TCM DaoyinAnxietyRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • 14-item Hamilton Anxiety Rating Scale

    The 14-item Hamilton Anxiety Rating Scale (HAMA-14) is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety. The HAMA-14 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 56. 29 or more on HAMA means severe anxiety disorders, 21 to 28 on HAMA means obvious anxiety disorders, 14 to 20 on HAMA means anxiety disorders, 8 to 13 on HAMA means suspicious anxiety disorders, 7 or less means no anxiety disorders.

    Change from Baseline HAMA-14 at 12 weeks

Secondary Outcomes (9)

  • 17-item Hamilton Depression Rating Scale

    Change from Baseline HAMD-17 at 12 weeks

  • Depression, Anxiety and Stress Scale-21 item

    Baseline

  • Depression, Anxiety and Stress Scale-21 item

    6 weeks

  • Depression, Anxiety and Stress Scale-21 item

    12 weeks

  • Functional magnetic resonance imaging (fMRI)

    Baseline

  • +4 more secondary outcomes

Study Arms (3)

TCM Daoyin intervention group

EXPERIMENTAL

Participants randomized to TCM Daoyin intervention group receive health education plus a TCM Daoyin training program. The TCM Daoyin training program was a 12-week, instructor-led group training program.

Behavioral: TCM DaoyinBehavioral: Health education

Health education control group

ACTIVE COMPARATOR

Participants randomized to the health education control group only receive health education and no additional training program.

Behavioral: Health education

Healthy Control

NO INTERVENTION

Healthy volunteers for data comparison, receiving no intervention.

Interventions

TCM DaoyinBEHAVIORAL

The TCM Daoyin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 12-weeks. All sessions included 10 min of warmup and 10 min of cooldown.

Also known as: Qigong
TCM Daoyin intervention group

Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.

Health education control groupTCM Daoyin intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject with a primary mental health complaint of anxiety.
  • Anxiety 14≤HAMA-14≤29, Depression 7≤HAMD-17\<14.
  • Subject has no history of psychotropic medication or has been off medication for more than 6 months.
  • Right-handed, aged 18 to 65, male or female.
  • Subject has a clear mind and the ability to lead an independent life.
  • Subject agrees to participate in fMRI scan and provide signed informed consent.

You may not qualify if:

  • Subject with definite clinical diagnosis of anxiety disorder and depression disorder by ICD-10.
  • Subject with bipolar disorder, psychotic disorder (e.g., schizophrenia), organic mental disorder (e.g., Alzheimer's disease).
  • Subject with alcohol abuse, substance dependence and suicidal ideation in past-year, or currently taking psychiatric medication, or current serious suicidal attempt.
  • Subject with serious current unstable medical illness.
  • Subject has claustrophobia, or any contraindication unable or unwilling to participate in fMRI scan.
  • Subject is clinically unable to participate in TCM Daoyin training program.
  • Subject is pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Qigong Research Institute

Shanghai, Shanghai Municipality, 021, China

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Qigong

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Breathing ExercisesMind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessors were blinded to the group allocation of the participants.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: This is a 12-week, randomized controlled trial with an additional healthy control group. Patients with anxiety state are randomized 1:1 to either the TCM Daoyin intervention group or the health education control group (10 participants each). Additionally, 10 healthy volunteers will be enrolled as a non-randomized healthy control group for data comparison.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant researcher

Study Record Dates

First Submitted

June 11, 2023

First Posted

July 6, 2023

Study Start

June 13, 2023

Primary Completion

March 20, 2025

Study Completion

March 20, 2025

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations